T cells with cell surface expression of adenosine deaminase and uses thereof

The present disclosure generally relates to compositions and methods for robust improvement of fitness and function of CAR T cells. More specifically, the present disclosure relates to novel chimeric polypeptides capable of anchoring adenosine deaminase activity to the surface of a T cell, nucleic a...

Full description

Saved in:
Bibliographic Details
Main Authors KRETZ DANIEL D, MCCALL CHRISTOPHER L
Format Patent
LanguageChinese
English
Published 18.06.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure generally relates to compositions and methods for robust improvement of fitness and function of CAR T cells. More specifically, the present disclosure relates to novel chimeric polypeptides capable of anchoring adenosine deaminase activity to the surface of a T cell, nucleic acids encoding the chimeric polypeptides, engineered T cells comprising the chimeric polypeptides or nucleic acids encoding the chimeric polypeptides. Also provided herein are methods of producing the engineered T cells, methods of administering the engineered T cells, and methods of treating an individual having a related health condition. 本公开文本总体上涉及用于稳健地改善CAR T细胞的适合度和功能的组合物和方法。更具体地,本公开文本涉及能够将腺苷脱氨酶活性锚定至T细胞表面的新型嵌合多肽、编码所述嵌合多肽的核酸、包含所述嵌合多肽或编码所述嵌合多肽的核酸的工程化T细胞。本文还提供了产生所述工程化T细胞的方法、施用所述工程化T细胞的方法和治疗具有相关健康情况的个体的方法。
Bibliography:Application Number: CN202280058061